Jay Lawrence Goodman - 20 Feb 2025 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Reporting relationship: Director
Issuer ticker: ATNF
Reported as of: 20 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Feb 2025, 18:27:29 UTC
Prior SEC filing: 29 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Jay Goodman

Key filing fact

Jay Lawrence Goodman filed Form 4 for 180 Life Sciences Corp. (ATNF) on 21 Feb 2025.

Key facts

This page summarizes Jay Lawrence Goodman's Form 4 filing for 180 Life Sciences Corp. (ATNF).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Feb 2025, 18:27.

Change

Previous filing in this sequence was filed on 29 Oct 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATNF transaction

Common Stock

Award

Transaction value: $0
Shares: +65,000
Change %
Price: $0.000000
Shares after: 65,000
Date: 20 Feb 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of July 1, 2025 and December 31, 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3.

Footnote F2

Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan.